(±)-<wbr/>Thalidomide-<wbr/>d<sub>4</sub>

(±)-Thalidomide-d4

CAT N°: 29450
Price:

231.00 196.35

(±)-Thalidomide-d4 is intended for use as an internal standard for the quantification of (±)-thalidomide (Item No. 14610) by GC- or LC-MS. (±)-Thalidomide is an immunomodulatory compound with diverse biological activities, including anticancer, anti-inflammatory, and teratogenic properties.{54394,54393,54392} It prevents polymorphonuclear leukocyte (PMN) chemotaxis when used at concentrations of 1, 10, and 100 µg/ml.{54394} (±)-Thalidomide increases IL-2-induced proliferation and IFN-? production in primary human T cells in vitro.{54393} It enhances natural killer (NK) cell-mediated cytotoxicity in MM.1S multiple myeloma cells.{54392} Thalidomide (4 mg/animal) reduces lung IL-6, TGF-?, VEGF, angiopoietin-1, angiopoietin-2, and collagen type I?1 expression, inhibits pulmonary angiogenesis, and attenuates fibrosis in a mouse model of bleomycin-induced pulmonary fibrosis.{54395} It induces apoptosis in primary human embryonic fibroblasts (EC50 = 8.9 µM) and induces limb and eye defects in chicken embryos (EC50 = 50 µg/kg egg weight).{54396} Formulations containing thalidomide have been used in the treatment of multiple myeloma and erythema nodosum leprosum (ENL) in non-pregnant individuals.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View